In the new research, Prins and Liau used a technique
called adoptive
cell transfer, which involves extracting and growing immune cells outside of the body, then reprogramming them with a gene known as New York Esophageal Squamous Cell Carcinoma, or NY - ESO
cell transfer, which involves extracting and growing immune
cells outside of the body, then reprogramming them with a gene known as New York Esophageal
Squamous Cell Carcinoma, or NY - ESO
Cell Carcinoma, or NY - ESO - 1.